What is Affymax, Inc. (AFFY)?

Affymax, Inc. (AFFY) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of AFFY?

The current price of AFFY is $0.00. Prices are updated in real time on Stocks360.

What is AFFY's price-to-earnings (PE) ratio?

AFFY's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is AFFY's market capitalization?

AFFY's market capitalization is $29,992.00, placing it in the small-cap tier.

Affymax, Inc. (AFFY)

Stock analysis · OTC · Healthcare · Biotechnology

$0.00

Market Cap

$29.99K

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

7.43

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.04

Avg Volume

N/A

Volume

170.00

Affymax, Inc. (AFFY) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $29.99K. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $0.00 2026-10-28 · $0.00 (+0.00%)

Earnings

Most Recent

Apr 2, 2013

EPS $-0.63 vs est. $-0.57

Missed by $0.06

Proprietary Signals

Signal snapshot temporarily unavailable.

About Affymax, Inc.

Affymax, Inc. presently lacks any substantial operational activities. In its earlier history, the firm concentrated on the creation of pharmaceutical agents designed to improve therapies for severe and frequently fatal health issues across the United States. Established in 2001, its corporate base is situated in New York, New York.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	0.02×
P/B	-0.02×
PEG	0.00×
P/FCF (TTM)	-0.00×
EV / EBITDA	0.39×
EV / Sales	-4.07×
Earnings Yield	-48146.76%
Free Cash Flow Yield	-224523.21%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	-$5.57M
Net Income (TTM)	-$14.44M
Free Cash Flow (TTM)	-$65.98M
Net Debt	-$5.60M
Working Capital	-$2.55M
Gross Margin	99.12%
Operating Margin	-1099.05%
Net Margin	-1053.62%
Return on Equity	-420.95%
Return on Invested Capital	916.52%